|
Verzögert
Bombay S.E.
09:15:40 15.10.2026
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 2’493.85 INR | -1.79% |
|
-1.62% | +0.91% |
| 03.08. | GSK India: Gewinn im ersten Quartal steigt dank stabiler Impfstoffnachfrage | RE |
| 03.08. | GlaxoSmithKline Pharmaceuticals Limited legt Ergebnisse für das erste Quartal zum 30. Juni 2026 vor | CI |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | Perf. 1 Jahr | Perf. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.33% | -1.15% | -10.96% | +0.80% | +1.40% | -8.44% | +62.75% | +69.91% | +69.35% | 4.52 Mrd. | ||
| +3.62% | +1.68% | +6.19% | +4.88% | +12.47% | +48.80% | +98.41% | +410.68% | +1’424.84% | 1’077 Mrd. | ||
| +2.13% | -1.76% | -4.66% | +0.02% | +22.69% | +33.04% | +61.88% | +58.58% | +115.98% | 612 Mrd. | ||
| +3.32% | +4.47% | +8.29% | +15.81% | +24.07% | +23.72% | +91.59% | +160.29% | +371.13% | 501 Mrd. | ||
| +3.80% | +3.21% | +1.74% | +22.02% | +40.01% | +73.99% | +41.69% | +88.14% | +137.16% | 364 Mrd. | ||
| +3.09% | +3.03% | +2.63% | +13.43% | +13.01% | +29.59% | +45.42% | +3.85% | +57.29% | 353 Mrd. | ||
| +2.82% | +2.20% | +7.67% | +0.20% | +11.92% | +17.90% | +40.15% | +60.42% | +62.68% | 278 Mrd. | ||
| +3.40% | +0.99% | +1.20% | -0.52% | -10.80% | -3.44% | +12.08% | +39.55% | +148.64% | 251 Mrd. | ||
| +3.21% | +3.15% | +11.69% | +19.95% | +30.19% | +45.01% | +49.99% | +106.07% | +163.19% | 230 Mrd. | ||
| +3.80% | +4.56% | +4.87% | +18.07% | +25.09% | +29.59% | +97.73% | +125.30% | +111.05% | 190 Mrd. | ||
| -0.27% | +0.81% | -8.72% | -19.94% | -21.31% | -29.03% | -64.28% | -20.84% | +89.24% | 168 Mrd. | ||
| +2.96% | +4.32% | +5.38% | +20.45% | +17.31% | +19.13% | -9.03% | -29.90% | -10.56% | 166 Mrd. | ||
| +2.74% | -1.41% | -4.04% | +4.66% | +9.96% | +20.93% | +34.37% | +174.05% | +529.18% | 126 Mrd. | ||
| +4.61% | -0.70% | -7.52% | +4.09% | +9.90% | +35.34% | +4.98% | +2.74% | +19.11% | 121 Mrd. | ||
| +1.53% | +7.28% | +7.20% | +21.56% | +19.05% | +24.90% | +111.12% | +380.93% | +506.57% | 114 Mrd. | ||
| +1.53% | +0.01% | -4.79% | -4.87% | -13.18% | -14.44% | -30.53% | -14.63% | +4.85% | 95.7 Mrd. | ||
| +3.59% | +1.42% | -2.08% | -5.44% | -0.47% | +10.90% | +20.26% | +3.64% | -14.09% | 95.69 Mrd. | ||
| +4.65% | +15.18% | +54.27% | +235.56% | +667.38% | +762.10% | +130.21% | -31.81% | - | 90.35 Mrd. | ||
| +3.35% | +4.88% | -1.94% | +18.63% | +0.84% | +35.93% | -7.30% | +40.09% | +109.42% | 77.72 Mrd. | ||
| +3.12% | +1.25% | +8.69% | +1.72% | +15.74% | +23.02% | -5.68% | -26.17% | +45.48% | 68.62 Mrd. | ||
| Durchschnitt | +2.12% | +2.36% | +3.76% | +18.55% | +43.76% | +58.93% | +39.29% | +80.04% | +207.40% | 249.27 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | +2.41% | +1.90% | +3.82% | +11.90% | +27.06% | +44.74% | +56.30% | +144.81% | +434.48% |
- Börse
- Aktien
- 946008 Aktie
- Sektor GlaxoSmithKline Pharmaceuticals Limited
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
















